Precos has signed a service agreement with Janssen Pharmaceutica that will see Precos provide clinical tumour material, tumour model development and more to support Janssen's oncology research.
The pre-clinical research and development service provider will provide target validation and drug efficacy work to support the pharmaceutical company's oncology drugs discovery, development and biomarker programmes.
Precos offers patient-relevant models that closely reflect the patient situation for each aspect of cancer progression encompassing pre-cancerous lesions, primary tumours and metastasis.
